Functionalizing Liposomes with anti-CD44 Aptamer for Selective Targeting of Cancer Cells.
about
Organic Nanomaterials and Their Applications in the Treatment of Oral DiseasesProgress and Challenges in Developing Aptamer-Functionalized Targeted Drug Delivery SystemsThe potential of liposomes with carbonic anhydrase IX to deliver anticancer ingredients to cancer cells in vivoAptamer-Mediated Targeted Delivery of Therapeutics: An UpdateAptamer-Drug ConjugatesSimultaneous targeting of CD44 and EpCAM with a bispecific aptamer effectively inhibits intraperitoneal ovarian cancer growth.Gastric cancer stem cells: evidence, potential markers, and clinical implications.Application of aptamers in diagnostics, drug-delivery and imaging.Lipid-based nanosystems for CD44 targeting in cancer treatment: recent significant advances, ongoing challenges and unmet needs.Engineering the RNA-Nanobio Interface.Liposomal Aerosols of Nitric Oxide (NO) Donor as a Long-Acting Substitute for the Ultra-Short-Acting Inhaled NO in the Treatment of PAH.Recent Advances in SELEX Technology and Aptamer Applications in Biomedicine.A nanoliposome-based photoactivable drug delivery system for enhanced cancer therapy and overcoming treatment resistance.Nucleic Acid Aptamers: Emerging Applications in Medical Imaging, Nanotechnology, Neurosciences, and Drug Delivery.Selection and targeting of EpCAM protein by ssDNA aptamer.Targeted Delivery of siRNA Therapeutics to Malignant Tumors.Aptamer-Based Therapeutic Approaches to Target Cancer Stem Cells.Surface Functionalization and Targeting Strategies of Liposomes in Solid Tumor Therapy: A Review.Large Stokes-shifted NIR-emission from nanospace-induced aggregation of perylenemonoimide-doped polymer nanoparticles: imaging of folate receptor expression.Non-Covalent Assembly Method that Simultaneously Endows a Liposome Surface with Targeting Ligands, Protective PEG Chains, and Deep-Red Fluorescence Reporter Groups.5TR1 aptamer-PEGylated liposomal doxorubicin enhances cellular uptake and suppresses tumour growth by targeting MUC1 on the surface of cancer cells.Supramolecular aptamer nano-constructs for receptor-mediated targeting and light-triggered release of chemotherapeutics into cancer cells."Clicking" gene therapeutics: A successful union of chemistry and biomedicine for new solutions.Synthesis of theranostic epithelial cell adhesion molecule targeted mesoporous silica nanoparticle with gold gatekeeper for hepatocellular carcinoma.The biology and role of CD44 in cancer progression: therapeutic implications.Antibody-modified liposomes for tumor-targeting delivery of timosaponin AIII.Five-Part Pentameric Nanocomplex Shows Improved Efficacy of Doxorubicin in CD44+ Cancer Cells.
P2860
Q26766613-FD12B699-E03A-4872-AFF0-820DF7D6E1BFQ26782485-8ADE669C-CD5C-44C9-ABB5-C525D6CEB1C7Q26827175-39C14B24-981D-4044-9AE6-F1B44527829DQ28066827-0AA3411E-93FD-40DB-AE6F-FE3E94AC5EADQ28468281-1B5C94AC-4B35-42F5-BC0C-760B1F4E603DQ33588273-2C9DC6C5-05CB-42D7-A1E8-3EE3F69D44A0Q35795934-DAD9F33B-F9C9-4E8E-BD5B-11E9AF15D30EQ38291061-653F301D-E0A1-40F0-96B3-95E9D257DAEDQ38889576-ADF9F9F3-BBE3-4952-A788-9327F0157651Q41513431-F288B854-71F8-4E31-BFA9-667E80B5D8CDQ42132055-4B214CDE-4370-47F8-9136-1A05C8737B41Q45265302-C734563B-53B6-46DA-8FC8-8570EA897EEAQ47098173-530F4327-8C42-4E26-AEC3-BB54CC157006Q47104247-3E02256B-FB87-4189-BA40-1A3BE3EFC078Q47134382-02CF459E-1D88-4E9C-8543-94449C8495B6Q47152520-9968A3DE-BD1E-464F-8915-972F4381F6D0Q47168257-A4175B50-952F-4CBC-A893-95E2F7BD52EEQ47190264-CDC03C33-D822-491A-A5F2-F38FCC45BF28Q47746153-3A9F96E3-70C9-4C1C-ABFD-5CA64A64CDB5Q48360404-9CDAF24D-D6E7-48BF-880B-16CB44CF99F4Q48581486-397B1BAF-D16F-4371-812C-B285FDC0861EQ49424319-1D9DC315-BE30-4CE4-97E2-3F1A70276212Q50195234-07C5145F-DE92-4462-A13F-59385F045869Q50640495-011AC056-139A-453A-9662-3C3F5DB3A19FQ54110894-7098FB6D-383F-4402-9E58-A032D556878DQ55084538-99BD4844-9E26-49A4-A683-EA34A8348DB2Q55657196-8B020BFE-E76C-4A86-AB56-7A1E9135185A
P2860
Functionalizing Liposomes with anti-CD44 Aptamer for Selective Targeting of Cancer Cells.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Functionalizing Liposomes with anti-CD44 Aptamer for Selective Targeting of Cancer Cells.
@en
type
label
Functionalizing Liposomes with anti-CD44 Aptamer for Selective Targeting of Cancer Cells.
@en
prefLabel
Functionalizing Liposomes with anti-CD44 Aptamer for Selective Targeting of Cancer Cells.
@en
P50
P356
P1476
Functionalizing Liposomes with anti-CD44 Aptamer for Selective Targeting of Cancer Cells
@en
P2093
Said Ismail
P304
P356
10.1021/BC5004313
P577
2014-11-07T00:00:00Z